Food allergies are on the rise,
with significant social, health, and economic impact
$25B
Each year is spent on healthcare costs related to food allergies and disorders
1 in every 13 children in
the United States is affected by food allergies
Every 3 minutes anaphylaxis sends someone to the E.R.
Ukko uses its advanced computational protein design platform to develop groundbreaking immuno-therapeutics for life-threatening allergies.
Our goal is to revolutionize allergy treatment and improve the lives of those affected.
We use our AI/protein micro-engineering platform to design new versions of allergens that do not trigger an allergic response but still re-educate the immune system to tolerate the allergen. This allows for a whole new approach to treating allergies
Leadership Team
URI LOPATIN
MD, CEO
YANAY OFRAN
PhD, Chairman & Co-founder
MATT OTTMER
COO
GRACE CHEN
MD, CMO
JUDITH WEISS PALTIEL
PhD, VP Development​
TIM SOOS
PhD, VP Translation Medicine
MOSHE BEN DAVID
PhD, CTO
SHARRON GARGOSKY
PhD, Acting CDO
Founders
ANAT BINUR
Co-Founder
YANAY OFRAN
Chairman &
Co-Founder
Our Advisors
DR. DANIEL ADELMAN
Former CMO of Aimmune Therapeutics, Alvine Pharmaceuticals & Sunesis;
Advisory board at FARE
DR. TIM GARNETT
Former CMO and SVP, Eli-Lily
DR. WESLEY A. BURKS
Stuart Bondurant Distinguished Professor
Dean and CEO UNC School of Medicine and UNC Health
DR. JAMES BAKER
Founding Director of
H. Weiser Food Allergy Center, Michigan University; CEO & CMO at FARE
PROF. STEPHEN DRESKIN
Medical Director, Allergy and Clinical Immunology
Professor of Medicine and Immunology
Children’s Hospital Colorado
PROF. LYNDA SCHNEIDER
Director, Allergy Program
Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School
DR. EDWIN KIM
Associate Professor, University of North Carolina; Director UNC Food Allergy Initiative
PROF. RAANAN SHAMIR
Chairman, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center
